Your post rang true with me. I have been a very interested spectator for a while now, and through my DD I have found that no one in the medical community I have asked has heard of Cellceutix. That, coupled with the technical chart that appears to have more downside, and the very good chance they will need to raise more funds before concluding studies on any of the drugs in the pipeline has made me hesitant to dip my toes in. If the price crashes, I may need to buy it out of necessity...just don't see any urgency to get in right now.